Chinese General Practice ›› 2020, Vol. 23 ›› Issue (7): 880-883.DOI: 10.12114/j.issn.1007-9572.2019.00.619
Special Issue: 肿瘤最新文章合辑; 共病最新文章合辑
• Monographic Research • Previous Articles Next Articles
Published:
2020-03-05
Online:
2020-03-05
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2019.00.619
[1]BARY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer Journal for Clinicians,2018,68(6):1-31.DOI:10.3322/caac.21492. [2]兰蓝,赵飞,蔡玥,等.中国居民2015年恶性肿瘤死亡率流行病学特征分析[J].中华流行病学杂志,2018,39(1):32-34.DOI:10.3760/cma.j.issn.0254-6450.2018.01.006. LAN L,ZHAO F,CAI Y,et al.Epidemiological analysis on mortality of cancer in China,2015[J].Chinese Journal of Epidemiology,2018,39(1):32-34.DOI:10.3760/cma.j.issn.0254-6450.2018.01.006. [3]HOFFE S,BALDUCCI L.Cancer and age:general considerations[J].Clin Geriatr Med,2012,28(1):1-18.DOI:10.1016/j.cger.2011.09.001. [4]BRIGHI N,BALDUCCI L,BIASCO G.Cancer in the elderly:is it time for palliative care in geriatric oncology?[J].Journal of Geriatric Oncology,2014,5(2):197-203.DOI:10.1016/j.jgo.2014.01.007. [5]刘文斌.社区老年人高血压流行病学调查[J].中国全科医学,2011,14(3):300-302.DOI:10.3969/j.issn.1007-9572.2011.03.025. LIU W B.Epidemiological survey of hypertension in aged patients of the community[J].Chinese General Practice,2011,14(3):300-302.DOI:10.3969/j.issn.1007-9572.2011.03.025. [6]NQ H S,KOCZWARA B,RODER D,et al.Changes in the prevalence of comorbidity in the Australian population with cancer,2007—2014[J].Cancer Epidemiology,2018,54:56-62.DOI:10.1016/j.canep.2018.03.010. [7]MORISHIMA T,MIYASHIRO I,MATSUMOTO Y,et al.Impact of comorbidities on survival in gastric,colorectal,and lung cancer patients[J].Journal of Epidemiology,2018,14:1-6.DOI:10.2188/jea.JE20170241. [8]FEINSTEIN A R.The pre-therapeutic classification of co-morbidity in chronic disease[J].J Chron Dis,1970,23:455-468.DOI:10.1016/0021-9681(70)90054-8. [9]World Health Organization.The world health report 2008:primary health cared now more than ever[R].Geneva:World Health Organization,2008. [10]于普林.老年医学[M].北京:人民卫生出版社,2017. [11]MENESES K,BENZ R,AZUERO A,et al.Multimorbidity and breast cancer[J].Seminars in Oncology Nursing,2015,31(2):163-169.DOI:10.1016/j.soncn.2015.02.004. [12]崔瑶,刘谦,秦明照.老年共病现状及管理策略[J].中国全科医学,2017,20(23):2816-2819.DOI:10.3969/j.issn.1007-9572.2017.06.y54. CUI Y,LIU Q,QIN M Z.Status and management strategies of multiple chronic conditions in older adults[J].Chinese General Practice,2017,20(23):2816-2819.DOI:10.3969/j.issn.1007-9572.2017.06.y54. [13]周玉洁,吕启圆,李现文.共病及共病指数研究进展与应用展望[J].中国公共卫生,2015,34(11):1513-1516.DOI:10.11847/zgggws2015-31-11-44. ZHOU Y J,Lyu Q Y,LI X W.Comorbidity and comorbidity index:a review[J].Chin J Public Health,2015,34(11):1513-1516.DOI:10.11847/zgggws2015-31-11-44. [14]蒲莉蓉,王敏,李志雄,等.边缘型人格障碍与精神疾病共病的研究进展[J].中国神经精神疾病杂志,2019,45(4):250-253. PU L R,WANG M,LI Z X,et al.Research progress on comorbidity between borderline personality disorder and mental illness[J].Chinese Journal of Neuropsychiatric Diseases,2019,45(4):250-253. [15]KENZIK K M,KENT E E,MARTIN M Y.Chronic condition clusters and functional impairment in older cancer survivors:a population-based study[J].J Cancer Surviv,2016,10(6):1096-1103.DOI:10.1007/s11764-016-0553-4. [16]胡小兰.社区老年慢性非传染性疾病共病的现况调查[D].北京:首都医科大学,2015. [17]王飞虎,张璐.抗抑郁药治疗偏头痛与抑郁症共病的研究进展[J].中国乡村医药,2019,26(7):74-75.DOI:CNKI:SUN:XCYY.0.2019-07-048. WANG F H,ZHANG L.Research progress in the treatment of migraine and depression with antidepressant[J].Chinese rural medicine,2019,26(7):74-75.DOI:CNKI:SUN:XCYY.0.2019-07-048. [18]GUISADOCLAVERO M,ROSOLLORACH A,LóPEZJIMENEZ T,et al.Multimorbidity patterns in the elderly:a prospective cohort study with cluster analysis[J].BMC Geriatrics,2018,18(1):16.DOI:10.1186/s12877-018-0705-7. [19]WILLIAMS G R,DEAL A M,LUND J L,et al.Patient-reported comorbidity and survival in older adults with cancer[J].Oncologist,2017,23(4):1-7.DOI:10.1634/theoncologist.2017-0404. [20]METTE S,WERNICH T R,SKOVGAARD B K,et al.The impact of comorbidity on cancer survival:a review[J].Clinical Epidemiology,2013,5(1):3-29.DOI:10.2147/CLEP.S47150. [21]J?RGENSEN T L,HALLAS J,FRIIS S,et al.Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality[J].British Journal of Cancer,2012,106(7):1353-1360.DOI:10.1038/bjc.2012.46. [22]ALEXANDRA P T,AMAIA C L,JORGE H S,et al.Multimorbidity patterns:a systematic review[J].Journal of Clinical Epidemiology,2014,67:254-266.DOI:10.1016/j.jclinepi.2013.09.021. [23]OKEDIJI P T.The pattern of comorbidities in cancer patients in Lagos,South-Western Nigeria[J].Ecancer Medical Science,2018,12(843):1-12.DOI:10.3332/ecancer.2018.843. [24]WU A H,KURIAN A W,KWAN M L,et al.Diabetes and other comorbidities in breast cancer survival by race/ethnicity:the California Breast Cancer Survivorship Consortium(CBCSC)[J].Cancer Epidemiol Biomarkers Prev,2015,24(2):361-368.DOI:10.1158/1055-9965.EPI-14-1140. [25]XUE S,ZE C,WILSON K.Real-world treatment patterns,comorbidities,and disease-related complications in patients with multiple myeloma in the United States[J].Current Medical Research & Opinion,2016,32(1):95-103.DOI:10.1185/03007995.2015.1105202. [26]SARFATI D.Review of methods used to measure comorbidity in cancer populations:no gold standard exists[J].Journal of Clinical Epidemiology,2012,65(9):924-933.DOI:10.1016/j.jclinepi.2012.02.017. [27]GANTI A K,SIEDLIK E,MARR A S,et al.Predictive ability of charlson comorbidity index on outcomes from lung cancer[J].American Journal of Clinical Oncology,2011,34(6):593-596.DOI:10.1097/COC.0b013e3181fe445b. [28]CHARLSON M E,POMPEI P,ALES K L.A New method of classifving prognostic comorbidity in longitudinal studies:development and validation[J].J Chronic Dis,1987,40(5):373-383.DOI:10.1016/0021-9681(87)90171-8. [29]WU C,HSU T,CHANG C,et al.Age-adjusted Charlson comorbidity index scores as predictor of survival in colorectal cancer patients who underwent surgical resection and chemoradiation[J].Medicine,2015,94(2):e431.DOI:10.1097/MD.0000000000000431. [30]SINGH B,BHAYA M,STERN J,et al.Validation of the Charlson comorbidity index in patients with head and neck cancer:a multi-institutional study[J].The Laryngoscope,1997,107(11 Pt 1):1469-1475.DOI:10.1097/00005537-199711000-00009. [31]LEE J Y,LEE D H,CHO N H,et al.Impact of Charlson comorbidity index varies by age in patients with prostate cancer treated by radical prostatectomy:a competing risk regression analysis[J].Annals of Surgical Oncology,2014,21(2):677-683.DOI:10.1245/s10434-013-3326-6. [32]王灯英.某三甲医院住院患者营养状况与老年共病相关性及其干预研究[D].青岛:青岛大学,2017. [33]SARIFATI D,KOCZWARA B,JACKSON C.The impact of comorbidity on cancer and its treatment[J].A Cancer Journal for Clinicians,2016,66:337-350.DOI:10.3322/caac.21342. [34]AHN D H,MEHTA N,YORIO J T,et al.Influence of medical comorbidities on the presentation and outcomes of stage i-iii non-small-cell lung cancer[J].Clinical Lung Cancer,2013,14(6):644-650.DOI:10.1016/j.cllc.2013.06.009. [35]GRANN A F,FROSLEV T,OLESEN A B,et al.The impact of comorbidity and stage on prognosis of Danish melanoma patients,1987—2009:a registry-based cohort study[J].British Journal of Cancer,2013,109(1):265-271.DOI:10.1038/bjc.2013.246. [36]李苏宜,沈干.肿瘤患者的“共病”[J].中国临床保健杂志,2016,19(5):449-450.DOI:10.3969/J.issn.1672-6790.2016.05.001. LI S Y,SHEN G.Comorbidity of cancer patients[J].Chinese Journal of Clinical Health Care,2016,19(5):449-450.DOI:10.3969/J.issn.1672-6790.2016.05.001. [37]PETRILLO L A,RITCHIE C S.The challenges of symptom management for patients with multimorbidity in research and practice:a thematic review[J].Progress in Palliative Care,2016,24(5):262-267.DOI:10.1080/09699260.2016.1192320. [38]LEE L,CHEUNG W Y,ATKINSON E,et al.Impact of comorbidity on chemotherapy use and outcomes in solid tumors:a systematic review[J].J Clin Oncol,2011,29:106-117.DOI:10.1586/17474086.2015.1024650. [39]SARFATI D,GURNEY J,STANLEY J,et al.A retrospective cohort study of patients with stomach and liver cancers:the impact of comorbidity and ethnicity on cancer care and outcomes[J].BMC Cancer,2014,14:821.DOI:10.1186/1471-2407-14-821. [40]JORGENSEN T L,TEIBLUM S,PALUDAN M,et al.Significance of age and comorbidity on treatment modality,treatment adherence,and prognosis in elderly ovarian cancer patients[J].Gynecologic Oncology,2012,127(2):367-374.DOI:10.1016/j.ygyno.2012.07.001. [41]BRADLEY C J,DAHMAN B,ANSCHER M.Prostate cancer treatment and survival evidence for men with prevalent comorbid conditions[J].Medical care,2014,52:482-489.DOI:10.1097/MLR.0000000000000113. [42]KORENHAKIM T,WEISS A,HERSHKOVITZ A,et al.The relationship between nutritional status of hip fracture operated elderly patients and their functioning,comorbidity and outcome[J].Clinical Nutrition,2012,6(1):917-921.DOI:10.1016/j.clnu.2012.03.010. [43]SOGAARD M,THOMSEN R,BOSSEN K,et al.The impact of comorbidity on cancer survival:a review[J].Clin Epidemiol,2013,5:3-29.DOI:10.2147/CLEP.S47150. [44]TüZüN H,AYCAN S,LHAN M N.Impact of comorbidity and socioeconomic status on quality of life in patients with chronic diseases who attend primary health care centres[J].Central European Journal of Public Health,2015,23(3):188-194.DOI:10.21101/cejph.a3990. [45]BACKEMAR L,WIKMAN A,DJ?RV T,et al.Co-morbidity after oesophageal cancer surgery and recovery of health-related quality of life[J].British Journal of Surgery,2016,103(12):1665-1675.DOI:10.1002/bjs.10248. [46]DOUNYA S,KAMILA C,PER H.The Impact of co-morbidity on health-related quality of life in breast cancer survivors and controls[J].Acta Oncologica,2015,54(5):727-734.DOI:10.3109/0284186X.2014.998277. [47]VISSERS P A,THONG M S,POUWER F,et al.The impact of comorbidity on health-related quality of life among cancer survivors:analyses of data from the profiles registry[J].J Cancer Surviv,2013,7:602-613.DOI 10.1007/s11764-013-0299-1. [48]WILLIAMS G R,MACKENZIE A,MAGNUSON A,et al.Comorbidity in older adults with cancer[J].Journal of Geriatric Oncology,2015,7(4):249-257.DOI:10.1016/j.jgo.2015.12.002. LIU S.The phenomenon of "abuse of the elderly" in China,its causes and countermeasures[J].Chinese Journal of Gerontology,2016,36(1):221-223. |
[1] | WANG Tingting, TANG Yong, ZHANG Wenke, LI Zhigang. Research Progress on Exercise Intervention of Hyperuricemia [J]. Chinese General Practice, 2025, 28(30): 3841-3846. |
[2] | XU Jialan, YAN Hong, WEN Jun, ZHOU Zitong, WANG Siyu. Prevalence of Potentially Inappropriate Medication in Older Adults with Cancer: a Meta-analysis [J]. Chinese General Practice, 2025, 28(30): 3815-3822. |
[3] | LI Hao, LI Peijin, LIU Tingting, CUI Yiyuan, LI Sicong, LIU Lixing, FENG Li, Working Group on Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment Guidelines for Cancer Pain. Guidelines on the Diagnosis and Treatment of Cancer Pain by Integrated Traditional Chinese and Western Medicine [J]. Chinese General Practice, 2025, 28(30): 3729-3740. |
[4] | CUI Yiyuan, YAN Yijing, WANG Ying, MENG Xiangju, ZHANG Qinglin, LIU Lixing, LI Sicong, FENG Li, The Working Group for the Clinical Practice Guideline for the Cancer-related Fatigue with Integrated Traditional Chinese and Western Medicine. Clinical Practice Guideline for the Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Cancer-related Fatigue [J]. Chinese General Practice, 2025, 28(27): 3345-3358. |
[5] | WANG Yajing, DUAN Xiaoyang, HOU Ran, HUANG Yajie, SHI Jian. Advances in Targeted Combination Therapy for Patients with Brain Metastases from EGFR-mutated Non-small Cell Lung Cancer [J]. Chinese General Practice, 2025, 28(26): 3328-3337. |
[6] | HUANG Yulin, WANG Haoyun, LI Yanmei, XIAO Xueying. Symptom Clusters in Gastric Cancer Patients Receiving Chemotherapy: a Scoping Review [J]. Chinese General Practice, 2025, 28(26): 3338-3344. |
[7] | SHANG Zhonghua, JIANG Zhiyue, HUANG Zhaohui, YANG Xing, LIU Haiyan, ZHANG Li. Trends in Cervical Cancer Burden in China from 1990 to 2021 and Prediction for 2022 to 2035 [J]. Chinese General Practice, 2025, 28(26): 3314-3320. |
[8] | YANG Chen, CHEN Tong, ZHANG Lifang, ZHANG Hongxu, LI Pengfei, ZHANG Xuejuan. Prognostic Impact of Dapagliflozin in Elderly Breast Cancer Survivors with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes [J]. Chinese General Practice, 2025, 28(24): 3053-3058. |
[9] | WANG Xiaolin, LI Qiuyue, ZHOU Yanjun, ZHANG Jinhui, LIANG Tao. Incidence and Risk of Cardiovascular Toxicity with Fruquintinib in Metastatic Colorectal Cancer: a Meta-analysis [J]. Chinese General Practice, 2025, 28(23): 2934-2940. |
[10] | RUAN Wanbai, LI Junfeng, YIN Yanmei, PENG Lei, ZHU Kexiang. Research Progress of Targeted Therapy and Immunotherapy for Pancreatic Cancer [J]. Chinese General Practice, 2025, 28(23): 2950-2960. |
[11] | ZHOU Qian, WU Xiaomin, WANG Baohua, YAN Ruohan, YU Miao, WU Jing. Study on Nomogram Prediction Model for Risk of Gastric Cancer [J]. Chinese General Practice, 2025, 28(23): 2870-2877. |
[12] | LUO Yunzhao, JIANG Hongchuan, XU Feng. Predicting Response to Neoadjuvant Therapy in Breast Cancer Using Deep Learning on Primary Core Needle Biopsy Slides [J]. Chinese General Practice, 2025, 28(19): 2407-2413. |
[13] | DENG Yaqian, CAO Chunli, MA Jinmei, LI Wenxiao, XU Zelin, CHENG Jing, LI Jun. Predictive Value of S-Detect Combined with Virtual Touch Tissue Imaging Quantification in Axillary Lymph Node Metastasis of Breast Cancer [J]. Chinese General Practice, 2025, 28(17): 2149-2155. |
[14] | CHENG Zhuozhuo, ZHANG Rui, XU Haofeng, HUANG Junting, LIANG Zijing, YAN Ping. Systematic Cluster Analysis of Comorbidity Patterns in Patients with Chronic Obstructive Pulmonary Disease and the Impact on Hospitalization Costs [J]. Chinese General Practice, 2025, 28(17): 2127-2133. |
[15] | CAO Chenchen, ZHENG Lyuyun, WANG Lin, LIU Jing. Preference Study on Family Doctor Contract Service among Patients with Hypertension and Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(16): 2011-2016. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||